MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Weight changes in PD patients post-DBS: A look at the factors involved

    B. Ahmed, L.B. Almeida, A. Bona, S. De Jesus, D. Martinez-Ramirez, M.S. Okun (Gainesville, FL, USA)

    Objective: To evaluate the factors associated with weight changes in Parkinson's disease (PD) patients after deep brain stimulation (DBS) surgery. Background: DBS is a well-established…
  • 2016 International Congress

    Suggested protocol for electroconvulsive therapy for depression in a Parkinson’s disease patient with a deep brain stimulator: A case report

    K. Dashtipour, M. Pereau, D. Trenkle, C. Osorio, K. Stoletniy (Loma Linda, CA, USA)

    Objective: To report an evidence for safety of ECT in patients with DBS in place. Background: We report a case of bilateral electroconvulsive therapy (ECT)…
  • 2016 International Congress

    Does GPi-DBS help non motor symptoms in cervical dystonia patients? A retrospective study of 17 patients

    L. Lowry, B. Hammersley, M. Bonello, P. Byrne, N.A. Fletcher, J.O. Farah, P.R. Eldridge, S.H. Alusi (Liverpool, United Kingdom)

    Objective: To study the efficacy of GPi DBS surgery in improving dystonia related severity, disability and pain as well as quality of life in medically…
  • 2016 International Congress

    Hand skin temperature and its response to cooling in clinical differentiation of multiple system atrophy and Parkinson’s disease

    S. Augustis, T. Fiesel, W.H. Jost (Kaunas, Lithuania)

    Objective: To determine the value of testing hand temperature and its response to cooling for differential diagnosis of multiple system atrophy (MSA) versus Parkinson's disease…
  • 2016 International Congress

    Imaging correlates of hypodipsia in progressive supranuclear palsy

    G. Respondek, T. Conrad, I. Riederer, T. Reeß, G. Rus, K. Koch, G. Höglinger, C. Zimmer (Munich, Germany)

    Objective: Aims of the present study were• to confirm hypodipsia as a characteristic feature of PSP and• to offer hypothesis on the pathological substrate for…
  • 2016 International Congress

    Do subjective ratings of the Parkinson’s disease sleep scale-2 converge with results from polysomnography in early Parkinson’s disease? – A report from the DeNoPa cohort

    F. Sixel-Döring, J. Zimmermann, M.L. Muntean, B. Mollenhauer, C. Trenkwalder (Kassel, Germany)

    Objective: To test whether subjective sleep perception is associated with objective sleep parameters by comparing video-polysomnographic (vPSG) data from Parkinson's disease (PD) patients with scorings…
  • 2016 International Congress

    Impulse control disorder associates with tyrosine hydroxylase 2 gene variants in Parkinson’s disease patients subject to dopaminergic therapy

    I. Legarda, B. Vives, C.A. Beltran-Gomila, B. Ortega-Vila, M. Ruiz, J. Pol-Fuster, C. Vives-Bauza (Palma, Spain)

    Objective: The aim of this study was to identify novel genetic variants associated with Impulse control disorder (ICD) manifestation in PD patients subject to dopaminergic…
  • 2016 International Congress

    Comparative study of the substantia nigra echogenicity and 123-I ioflupane SPECT in patients with REM behavior disorder

    J. Mašková, P. Dušek, D. Školoudík, K. Kupka, K. Šonka, V. Ibarburu Lorenzo Y Losada, J. Kubinyi, E. Ruzicka (Praha 2, Czech Republic)

    Objective: To compare (1) the echogenicity of substantia nigra (SN) in subjects with idiopathic REM behavior disorder (iRBD) and healthy controls and (2) to determine…
  • 2016 International Congress

    The basal ganglia muscarine receptors impairment in progressive supranuclear palsy

    B. Muinjonov, E. Giyaziddinova, G. Rakhimbaeva (Tashkent, Uzbekistan)

    Objective: To measure muscarinic M2 and M4 receptors in the basal ganglia in PSP. Background: Progressive supranuclear palsy is a nuerodegenerative Parkinson's plus syndrome. This…
  • 2016 International Congress

    Sniffing the diagnosis: Olfactory testing in neurodegenerative parkinsonism

    F. Krismer, B. Pinter, C. Müller, P. Mahlknecht, M. Nocker, E. Reiter, A. Djamshidian-Tehrani, S.M. Bösch, G.K. Wenning, C. Scherfler, W. Poewe, K. Seppi (Innsbruck, Austria)

    Objective: To determine the diagnostic utility of olfactory testing in patients with neurodegenerative parkinsonism. Background: Olfactory dysfunction can be identified in the vast majority of…
  • « Previous Page
  • 1
  • …
  • 116
  • 117
  • 118
  • 119
  • 120
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
      • Welcome to the MDS Abstracts Site
      • Effect of marijuana on Essential Tremor: A case report
      • Advanced Search
      • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
      • Covid vaccine induced parkinsonism and cognitive dysfunction
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley